249 related articles for article (PubMed ID: 24071579)
1. Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection.
Zhong Y; Liu B; Deng M; Xu R
Drug Discov Ther; 2013 Aug; 7(4):164-6. PubMed ID: 24071579
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
[TBL] [Abstract][Full Text] [Related]
4. Postoperative therapy options for hepatocellular carcinoma.
Zhong JH; Ma L; Li LQ
Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Miyazaki I
Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
[TBL] [Abstract][Full Text] [Related]
6. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
7. Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence.
Andreana L; Burroughs AK
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S249-57. PubMed ID: 20547311
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatments for resectable hepatocellular carcinoma.
Ishii H; Yamamoto J; Ikari T
J Hepatobiliary Pancreat Surg; 2008; 15(5):459-62. PubMed ID: 18836796
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Kudo M
Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
[TBL] [Abstract][Full Text] [Related]
10. Impact of interferon therapy after curative treatment of hepatocellular carcinoma.
Kudo M
Oncology; 2008; 75 Suppl 1():30-41. PubMed ID: 19092270
[TBL] [Abstract][Full Text] [Related]
11. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Ueno M; Uchiyama K; Ozawa S; Hayami S; Shigekawa Y; Tani M; Yamaue H
Ann Surg Oncol; 2011 Dec; 18(13):3624-31. PubMed ID: 21614626
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
Saab S; McTigue M; Finn RS; Busuttil RW
Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
[TBL] [Abstract][Full Text] [Related]
14. Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib.
Frenette CT; Frederick RT; Gish RG
J Clin Gastroenterol; 2011 Sep; 45(8):733-7. PubMed ID: 20930642
[TBL] [Abstract][Full Text] [Related]
15. Surgery and transplantation for hepatocellular cancer.
Wall WJ; Marotta PJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?
Fujiki M; Aucejo F; Kim R
Clin Transplant; 2013; 27(2):169-77. PubMed ID: 23216662
[TBL] [Abstract][Full Text] [Related]
17. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
[TBL] [Abstract][Full Text] [Related]
18. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
19. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.
Sun HC; Tang ZY; Wang L; Qin LX; Ma ZC; Ye QH; Zhang BH; Qian YB; Wu ZQ; Fan J; Zhou XD; Zhou J; Qiu SJ; Shen YF
J Cancer Res Clin Oncol; 2006 Jul; 132(7):458-65. PubMed ID: 16557381
[TBL] [Abstract][Full Text] [Related]
20. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
